Kite Pharma (KITE) Posts Q4 Loss of 85c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall Street ends choppy session lower as tech shares drop
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
- Oil prices fall 1% to 4-month lows as progress in US-Iran talks cools supply concerns
- Trump discloses over $1.4 billion in crypto income in 2025 filing
Jefferies Reiterates Buy on Kite Pharma (KITE) Following a Mixed 4Q - PT to $75
March 1, 2016 9:31 AM ESTJefferies maintained a Buy rating on Kite Pharma (NASDAQ: KITE), and cut the price target to $75.00 (from $92.00), following the company's 4Q earnings conference call. KITE reported Q4 revenues of $4.9M, coming in ahead of Jefferies' estimate of $4.4M. GAAP EPS of ($0.85) also beat estimates... More
Citi Starts Kite Pharma (KITE) at Buy
February 25, 2016 8:25 AM ESTCiti initiatesd coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $67.00.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $44.97 yesterday.
... More